IP Library Granted Patent US 7,973,156
Granted Patent B2
US 7,973,156 · App. 12/157,821 · Granted Jul 5, 2011

Hypoxia-regulated genes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,973,156
App. No.
12/157,821
Granted
Jul 5, 2011
Kind
B2
Abstract

According to the present invention, purified, isolated and cloned nucleic acid polynucleotide encoding hypoxia-regulating genes and the proteins thereof and antibodies directed against the proteins which have sequences as set forth in SEQ ID No:1, SEQ ID No:2, SEQ ID No:3, SEQ ID No:4, SEQ ID No:5 and SEQ ID No:6 are provided. The present invention further provides transgenic animals and cell lines as well as knock-out organisms of these sequences. The present invention further provides methods of regulating angiogenesis or apoptosis or regulating response to hypoxic conditions in a patient in need of such treatment. The present invention also provides a method of diagnosing the presence of ischemia in a patient including the steps of analyzing a bodily fluid or tissue sample from the patient for the presence or gene product of at least one expressed gene (up-regulated) as set forth in the group comprising SEQ ID No:2; SEQ ID No:3; SEQ ID No:4; SEQ ID No:5; and SEQ ID No:6 and where ischemia is determined if the up-regulated gene or gene product is ascertained.

Claims (3)

1. An antisense RNA molecule which inhibits the activity of a polypeptide the amino acid sequence of which is set forth in SEQ ID NO: 10.

2. The RNA molecule of claim 1 wherein the inhibiting comprises preventing processing, splicing, transport or translation of mRNA encoding the polypeptide.

3. The RNA molecule of claim 1 wherein the inhibiting results in mRNA degradation.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2008
From: EINAT, PAZ; SKALITER, RAMI; LURIA, SYLVIE
To: QUARK PHARMACEUTICALS, INC.
Reel/Frame 021675/0826 →